Clinical Trial Results: A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety, tolerability, and immune response of a meningococcal ABCWY vaccine in healthy infants; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal ABCWY vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 2 | Status: COMPLETED | Results posted: 2026-06-26